Bradford D. Dahms
CIK: 0001787307
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
JBIO
Jade Biosciences, Inc.
Officer
Discretionary Trading P&L
Holdings
About Dahms Bradford D.
Dahms Bradford D. (SEC CIK 0001787307) files insider reports with the SEC as Chief Financial Officer of Jade Biosciences, Inc. (JBIO).
Signal8 holds 3 ownership filings by Dahms Bradford D. (1 Form 3, 2 Form 4), filed between Jul 14, 2025 and Feb 13, 2026. Those filings report 2 transactions, from Jul 14, 2025 to Feb 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Dahms Bradford D.'s filings is in WALTHAM, MA.
Recent filings by Dahms Bradford D.
Other insiders filing for Jade Biosciences, Inc. (JBIO)
- Eisner Mark, Director
- CAIN CHRISTOPHER W., Director
- DOBMEIER ERIC, Director
- Klein Lawrence Otto, Director
- Lavelle Erin, Director
- Fairmount Funds Management LLC, Director